103 related articles for article (PubMed ID: 283726)
1. Toward a coherent system of narcotic addiction treatment.
Dogoloff LI
Ann N Y Acad Sci; 1978; 311():296-301. PubMed ID: 283726
[No Abstract] [Full Text] [Related]
2. Recent developments in chemotherapy of narcotic addiction, 3-4 November 1977, Washington, D.C.: proceedings.
Ann N Y Acad Sci; 1978; 311():1-315. PubMed ID: 33587
[No Abstract] [Full Text] [Related]
3. General overview of narcotic addiction treatment programs.
Bourne PG
Ann N Y Acad Sci; 1978; 311():147-52. PubMed ID: 283715
[No Abstract] [Full Text] [Related]
4. Recent developments in chemotherapy of narcotic addiction. Part VI. LAAM and narcotic antagonists: introductory remarks.
Jasinski DR
Ann N Y Acad Sci; 1978; 311():197-8. PubMed ID: 283720
[No Abstract] [Full Text] [Related]
5. Methadone and 1-methadyl acetate: use in management of narcotic addicts. 1971 [proceedings].
Jaffe JH; Senay EC
NIDA Res Monogr; 1976 Jul; (8):74-5. PubMed ID: 792703
[No Abstract] [Full Text] [Related]
6. 1-Alpha-acetylmethoadol in the treatment of opiate addiction: progress report. 1971 [proceedings].
Blachly PH
NIDA Res Monogr; 1976 Jul; (8):55-6. PubMed ID: 995177
[No Abstract] [Full Text] [Related]
7. The SAODAP cooperative studies of LAAM: unblinded comparison with methadone.
Klett CJ
NIDA Res Monogr; 1978; (19):271-6. PubMed ID: 106292
[No Abstract] [Full Text] [Related]
8. Multimodality treatment of narcotic addiction: an overview.
Woody GE; O'Brien CP; Greenstein R
NIDA Res Monogr; 1978; (19):226-40. PubMed ID: 106287
[TBL] [Abstract][Full Text] [Related]
9. Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002.
Colker AC
Issue Brief Health Policy Track Serv; 2002 Dec; ():1-6. PubMed ID: 12875273
[No Abstract] [Full Text] [Related]
10. Pharmacotherapy of opiate addiction.
Swanson DA
S Afr Med J; 1976 May; 50(22):857-9. PubMed ID: 935974
[TBL] [Abstract][Full Text] [Related]
11. How effective is LAAM treatment? Clinical comparison with methadone.
Zangwell BC; McGahan P; Dorozynsky L; McLellan AT
NIDA Res Monogr; 1986; 67():249-55. PubMed ID: 3092073
[No Abstract] [Full Text] [Related]
12. Heroin maintenance for heroin addicts: issues and evidence.
Koran LM
N Engl J Med; 1973 Mar; 288(13):654-60. PubMed ID: 4568989
[No Abstract] [Full Text] [Related]
13. NIDA's Medication Development Program--1989.
Schuster CR; Snyder M
NIDA Res Monogr; 1989; 95():64-73. PubMed ID: 2641056
[No Abstract] [Full Text] [Related]
14. Reflections on the epidemiology of heroin and narcotic addiction from the perspective of treatment data.
Sells SB
NIDA Res Monogr; 1977 Nov; 16():147-76. PubMed ID: 97548
[No Abstract] [Full Text] [Related]
15. Drug abuse control: policy turns toward rehabilitation.
Walsh J
Science; 1971 Jul; 173(3991):32-4. PubMed ID: 5087477
[TBL] [Abstract][Full Text] [Related]
16. [Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal].
Patricio LD; Miguel N
Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():28-30. PubMed ID: 7880010
[No Abstract] [Full Text] [Related]
17. International challenge of drug abuse: a perspective from the United States.
DuPont RL
NIDA Res Monogr; 1978; (19):3-14. PubMed ID: 106295
[No Abstract] [Full Text] [Related]
18. Actions and addiction liabilities of alpha-acetylmethadols in man. 1952 [proceedings].
Fraser HF; Isbell H
NIDA Res Monogr; 1976 Jul; (8):58-2. PubMed ID: 995179
[No Abstract] [Full Text] [Related]
19. Can the community be protected against the hazards of take-home methadone? 1974 [proceedings].
Goldstein A; Judson B
NIDA Res Monogr; 1976 Jul; (8):62-3. PubMed ID: 792698
[No Abstract] [Full Text] [Related]
20. The Campbell Collaboration. Does for public policy what cochrane does for health.
Davies P; Boruch R
BMJ; 2001 Aug; 323(7308):294-5. PubMed ID: 11498472
[No Abstract] [Full Text] [Related]
[Next] [New Search]
